Urinary liquid biopsy (LB) tests have contributed to reducing overtreatment and improving
the detection of bladder and prostate cancer. Circulating tumor cells, DNA, and RNA are the …

Prostate cancer (PCa) is the second most frequent type of cancer in men and assessing
circulating tumor cells (CTCs) by liquid biopsy is a promising tool to help in cancer early …

Circulating free DNA (cfDNA) is in use for the non-invasive diagnosis of tumors. Methylation
of tumor suppressor genes (TSGs) is an early event in carcinogenesis and may serve as …

Biliary tract cancers are heterogeneous in etiology, morphology and molecular
characteristics thus impacting disease management. Diagnosis is complex and prognosis …

The background to this debate is now well-known: an EU policy decision to tighten controls
on the devices and diagnostics sector led to the adoption of a regulation in 2017 with a …

Purpose To investigate the predictive performance of the combined model by integrating
clinical variables and radiomic features for the accurate detection of prostate cancer (PCa) in …

Background Current management of prostate cancer (PC) lacks biomarker tests and
diagnostic procedures that can accurately distinguish clinically significant and clinically …

Robot-assisted prostate biopsy is a new technology to diagnose prostate cancer, but its
safety is influenced by the inability of robots to sense the tool-tissue interaction force …

Purpose To investigate the value of serum free prostate-specific antigen density (fPSAD) in
the diagnosis of prostate cancer (PCa). Methods The data of 558 patients who underwent …

Prostate cancer (PCa) screening remains one of the most controversial topics in clinical and
public health. Despite being the second most common cancer in men worldwide …